XML 63 R44.htm IDEA: XBRL DOCUMENT v2.4.1.9
Segment and Other Information (Tables)
12 Months Ended
Dec. 31, 2014
Segment Reporting [Abstract]  
Summary Of Total Revenues
The following table presents a summary of total revenues (in thousands): 
 
Year Ended December 31,
 
2014
 
2013
 
2012
Xyrem
$
778,584

 
$
569,113

 
$
378,663

Erwinaze/Erwinase
199,665

 
174,251

 
72,083

Defitelio/defibrotide
70,537

 

 

Prialt® (ziconotide) intrathecal infusion
26,421

 
27,103

 
26,360

Psychiatry
40,879

 
49,226

 
76,489

Other
46,630

 
45,705

 
26,932

Product sales, net
1,162,716

 
865,398

 
580,527

Royalties and contract revenues
10,159

 
7,025

 
5,452

Total revenues
$
1,172,875

 
$
872,423

 
$
585,979

Summary Of Total Revenues Attributed To Geographic Sources
The following table presents a summary of total revenues attributed to geographic sources (in thousands): 
 
Year Ended December 31,
 
2014
 
2013
 
2012
United States
$
1,007,396

 
$
792,518

 
$
538,219

Europe
126,715

 
61,843

 
38,590

All other
38,764

 
18,062

 
9,170

Total revenues
$
1,172,875

 
$
872,423

 
$
585,979

Summary Of Revenues From Customers Representing More Then 10% Of Total Revenues
The following table presents a summary of the percentage of total revenues from customers that represented more than 10% of our total revenues: 
 
Year Ended December 31,
 
2014
 
2013
 
2012
Express Scripts
66
%
 
65
%
 
64
%
Accredo
14
%
 
16
%
 
N/A

Total Long-Lived Assets by Location
The following table presents total long-lived assets by location (in thousands): 
 
December 31,
 
2014
 
2013
Ireland
$
37,775

 
$
5,799

United States
9,795

 
7,734

Italy
8,462

 

Other
2,331

 
713

Total long-lived assets
$
58,363

 
$
14,246

_________________________
(1)
    Long-lived assets consist of property and equipment.